Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8518403 Expression-enhanced polypeptides

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 15, 2005
0
Date of Patent
August 27, 2013
0
Patent Application Number
11572116
0
Patent Citations Received
‌
US Patent 12129300 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11884733 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11884732 Proteins binding HER2, NKG2D and CD16
0
‌
US Patent 11939384 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11753469 Methods of using bispecific CD33 and CD3 binding proteins
‌
US Patent 11834506 Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8518403
0
Patent Primary Examiner
‌
Karen Canella
0

Find more entities like US Patent 8518403 Expression-enhanced polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.